These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9349007)

  • 1. [One-sided and tendentious article on Mustine].
    Hjort F; Thestrup-Pedersen K
    Sygeplejersken; 1997 Jun; 97(24):34-5. PubMed ID: 9349007
    [No Abstract]   [Full Text] [Related]  

  • 2. [Explanation of the mustine saga].
    Kayser E; Holmboe K
    Sygeplejersken; 1997 Jul; 97(29):20-1. PubMed ID: 9362930
    [No Abstract]   [Full Text] [Related]  

  • 3. [Can cutaneous intolerance reactions to caryolysine be prevented or controlled?].
    Ann Dermatol Venereol; 1997; 124(9):662-4. PubMed ID: 9739933
    [No Abstract]   [Full Text] [Related]  

  • 4. Common stem: -mustine.
    Prescrire Int; 2012 Mar; 21(125):67. PubMed ID: 22428186
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary transitional cell carcinoma and nitrogen mustard treatment.
    DeLair SM; White RW; Kurzrock EA
    Urology; 2005 Jun; 65(6):1226-7. PubMed ID: 15922437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic chemotherapy for cancer: from weapon to treatment.
    Joensuu H
    Lancet Oncol; 2008 Mar; 9(3):304. PubMed ID: 18308256
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
    Northrup NC; Gieger TL; Kosarek CE; Saba CF; LeRoy BE; Wall TM; Hume KR; Childress MO; Keys DA
    Vet Comp Oncol; 2009 Mar; 7(1):38-44. PubMed ID: 19222829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
    de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
    Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mustine: work environment--conflict in work process. Interview by Claus Leick].
    Holmboe K
    Sygeplejersken; 1997 May; 97(20):11. PubMed ID: 9470772
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mustine: work environment--it costs blood sweat and tears. Interview by Claus Leick].
    Holmboe K
    Sygeplejersken; 1997 May; 97(20):12-3. PubMed ID: 9470773
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mustine: work environment--insecurity never ceases].
    Leick C
    Sygeplejersken; 1997 May; 97(20):6-10. PubMed ID: 9470771
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rules for prevention and certification of occupational diseases in workers occupationally exposed to antineoplastic drugs].
    Walusiak J; Wagrowska-Koski E; Pałczyński C
    Med Pr; 2001; 52(1):39-44. PubMed ID: 11424747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk assessment concerning hospital personnel participating in the preparation and administration of antineoplastic drugs].
    Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Frigerio F; Draicchio F; Apostoli P
    G Ital Med Lav Ergon; 1999; 21(2):93-107. PubMed ID: 10771723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
    van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
    J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related leukemia associated with alkylating agents.
    Davies SM
    Med Pediatr Oncol; 2001 May; 36(5):536-40. PubMed ID: 11340608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational risk in health care and research.
    Vecchio D; Sasco AJ; Cann CI
    Am J Ind Med; 2003 Apr; 43(4):369-97. PubMed ID: 12645094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by amifostine of cyclophosphamide-induced myelosuppression.
    Alberts DS
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):37-40. PubMed ID: 10348259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemo quick guide: alkylating agents.
    Greifzu S
    RN; 1996 Feb; 59(2):53-6. PubMed ID: 8685611
    [No Abstract]   [Full Text] [Related]  

  • 20. Temozolomide and anaplastic astrocytoma: new indication. No clear proof of efficacy.
    Prescrire Int; 2000 Dec; 9(50):170-1. PubMed ID: 11475493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.